Screening Synthetic Adulterants from Herbal and Dietary Supplements (HDS) Using the Natural Products Application Solution with UNIFI
Applications | 2015 | WatersInstrumentation
Adulteration of herbal and dietary supplements with undeclared synthetic drugs presents significant health and regulatory challenges. Reports of severe adverse events, including fatal outcomes, underscore the need for robust analytical approaches. High‐performance liquid chromatography coupled with high‐resolution mass spectrometry (LC–MS) is a gold‐standard technique for detecting trace synthetic adulterants in complex botanical matrices, but streamlined, user‐friendly workflows are essential to improve throughput and consistency.
This study demonstrates a turnkey solution for rapid screening and confirmation of synthetic adulterants in a commercial anti‐inflammatory herbal supplement. Using the Natural Products Application Solution powered by UNIFI software and a dedicated Synthetic Adulterants Library, the workflow integrates sample preparation, data acquisition, automated component identification, fragment ion verification, and report generation into a single, efficient process.
Analysis of a street‐vendor herbal capsule revealed two nonsteroidal anti‐inflammatory drug (NSAID) adulterants: phenylbutazone (direct library match) and its metabolite oxyphenbutazone (identified via structural elucidation). Phenylbutazone met parent mass and diagnostic fragment criteria within 2 mDa mass error. A high‐abundance unknown component at 8.29 min was subjected to elemental composition determination (C19H20N2O3, i-FIT 99.9%), online ChemSpider search, and MassFragment prediction of MS/MS fragments, confirming oxyphenbutazone. Automated review templates categorized “Good Matches,” “Tentative Matches,” and “No Match High Intensity,” enabling focused confirmation workflows and rapid report generation.
• Fully integrated, sample‐to‐report pipeline reduces manual intervention, operator expertise, and processing time.
• Dedicated Synthetic Adulterants Library enhances detection of common and emerging synthetic drugs.
• Automated fragment verification minimizes false positives and supports confident identification.
• Scalable workflow adaptable for routine quality control, contract testing, and regulatory monitoring.
• Expansion of adulterant libraries to include novel synthetic analogues and region‐specific compounds.
• Integration of machine learning models to prioritize unknown high‐intensity peaks for structural elucidation.
• Application of similar workflows to other complex natural product matrices (e.g., botanical extracts, traditional medicines).
• Cloud‐based data sharing and collaborative annotation to support global surveillance of adulterated products.
The Natural Products Application Solution with UNIFI Adulterant Screening Application offers a robust, high‐throughput approach for detecting and confirming synthetic adulterants in herbal supplements. The combination of LC–MS data‐independent acquisition, a comprehensive adulterant library, and automated processing workflows delivers rapid, reliable results with minimal expert input, meeting the demands of modern quality assurance and regulatory environments.
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesPharma & Biopharma
ManufacturerWaters
Summary
Significance of the Topic
Adulteration of herbal and dietary supplements with undeclared synthetic drugs presents significant health and regulatory challenges. Reports of severe adverse events, including fatal outcomes, underscore the need for robust analytical approaches. High‐performance liquid chromatography coupled with high‐resolution mass spectrometry (LC–MS) is a gold‐standard technique for detecting trace synthetic adulterants in complex botanical matrices, but streamlined, user‐friendly workflows are essential to improve throughput and consistency.
Objectives and Overview of the Study
This study demonstrates a turnkey solution for rapid screening and confirmation of synthetic adulterants in a commercial anti‐inflammatory herbal supplement. Using the Natural Products Application Solution powered by UNIFI software and a dedicated Synthetic Adulterants Library, the workflow integrates sample preparation, data acquisition, automated component identification, fragment ion verification, and report generation into a single, efficient process.
Methodology
- Sample preparation: 1 g of powdered supplement extracted in 10 mL LC–MS grade methanol, sonicated for 20 min, centrifuged at 4472 g for 5 min, 250× dilution, 1 µL injection.
- Chromatographic separation: Waters ACQUITY UPLC I-Class with HSS T3 column (2.1×100 mm, 1.8 µm) at 40 °C; 17 min gradient from 2% to 100% acetonitrile (0.1% formic acid).
- Mass spectrometry: Xevo G2-XS QTof operated in ESI+ and ESI– with MS E data‐independent acquisition; scan range 50–1500 Da; low collision energy 6 eV, high collision energy ramp 10–40 eV; resolution mode with lock mass correction.
- Data processing: UNIFI Adulterant Screening Application employing seven preset workflows linked to the Synthetic Adulterants Library for automated peak picking, library matching, fragment verification, and report generation.
Instrumentation Used
- Waters ACQUITY UPLC I-Class System with Flow Through Needle (FTN) sample manager
- Waters Xevo G2-XS QTof Mass Spectrometer
- Natural Products Application Solution with UNIFI software
- Catechin standard mixture for system suitability testing
Main Results and Discussion
Analysis of a street‐vendor herbal capsule revealed two nonsteroidal anti‐inflammatory drug (NSAID) adulterants: phenylbutazone (direct library match) and its metabolite oxyphenbutazone (identified via structural elucidation). Phenylbutazone met parent mass and diagnostic fragment criteria within 2 mDa mass error. A high‐abundance unknown component at 8.29 min was subjected to elemental composition determination (C19H20N2O3, i-FIT 99.9%), online ChemSpider search, and MassFragment prediction of MS/MS fragments, confirming oxyphenbutazone. Automated review templates categorized “Good Matches,” “Tentative Matches,” and “No Match High Intensity,” enabling focused confirmation workflows and rapid report generation.
Benefits and Practical Applications of the Method
• Fully integrated, sample‐to‐report pipeline reduces manual intervention, operator expertise, and processing time.
• Dedicated Synthetic Adulterants Library enhances detection of common and emerging synthetic drugs.
• Automated fragment verification minimizes false positives and supports confident identification.
• Scalable workflow adaptable for routine quality control, contract testing, and regulatory monitoring.
Future Trends and Potential Applications
• Expansion of adulterant libraries to include novel synthetic analogues and region‐specific compounds.
• Integration of machine learning models to prioritize unknown high‐intensity peaks for structural elucidation.
• Application of similar workflows to other complex natural product matrices (e.g., botanical extracts, traditional medicines).
• Cloud‐based data sharing and collaborative annotation to support global surveillance of adulterated products.
Conclusion
The Natural Products Application Solution with UNIFI Adulterant Screening Application offers a robust, high‐throughput approach for detecting and confirming synthetic adulterants in herbal supplements. The combination of LC–MS data‐independent acquisition, a comprehensive adulterant library, and automated processing workflows delivers rapid, reliable results with minimal expert input, meeting the demands of modern quality assurance and regulatory environments.
References
- Posadki P, et al. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol. 2013 Mar;69(3):295–307.
- Qiao L, Lewis R, Hooper A, Morphet J, Tan X, Yu K. Using Natural Products Application Solution with UNIFI for the Identification of Chemical Ingredients of Green Tea Extract. Waters Application Note. 2013. (p/n 720004837EN).
- Qiao L, Lewis R, Hooper A, Morphet J, Tan X, Yu K. Using Natural Products Application Solution with UNIFI for comparison of Chemical Ingredients of Shuanghuanglian Oral Drink from Two Manufacturers. Waters Application Note. 2013. (p/n 720004842EN).
- Qiao L, Lewis R, Hooper A, Morphet J, Tan X, Yu K. Using Natural Products Application Solution with UNIFI to Identify Chemical Ingredients and Deduce Possible Herbal Composition from Unknown Traditional Medicine Tablets. Waters Application Note. 2013. (p/n 720004840EN).
- Inman WH. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J. 1977 Jun 11;1(6075):1500–5.
- Qiao L, Yu K. Using the elucidation tool in UNIFI Scientific Information System to identify unknown compounds in natural products. Waters Application Note. 2014. (p/n 720004876EN).
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Detection and Identification of Synthetic Phosphodiesterase Type-5 Inhibitors in Adulterated Herbal Supplements Using UPLC and Data-Directed Analysis by Mass Spectrometry
2015|Waters|Applications
Detection and Identification of Synthetic Phosphodiesterase Type-5 Inhibitors in Adulterated Herbal Supplements Using UPLC and Data-Directed Analysis by Mass Spectrometry Marian Twohig, Andrew Aubin, Michael Jones, and Robert S. Plumb Waters Corporation, Milford, MA, USA INT RODUC T ION There…
Key words
scanwave, scanwavetadalafil, tadalafilsildenafil, sildenafiltic, ticvardenafil, vardenafilhds, hdsherbal, herbaladulteration, adulterationpatient, patientsupposed, supposedxevo, xevouplc, uplcsynthetic, syntheticsurvey, surveyadulterated
Using Natural Products Application Solution with UNIFI to Identify Chemical Ingredients and Deduce Possible Herbal Composition from Unknown Traditional Medicine Tablets
2013|Waters|Applications
Using Natural Products Application Solution with UNIFI to Identify Chemical Ingredients and Deduce Possible Herbal Composition from Unknown Traditional Medicine Tablets Lirui Qiao,1 Rob Lewis,2 Alex Hooper,2 James Morphet,2 Xiaojie Tan,1 Kate Yu 3 1 Waters Corporation (Shanghai), Shanghai, China…
Key words
unifi, unifiingredients, ingredientsnatural, naturalherbal, herbaldeduce, deducechemical, chemicalidentify, identifyproducts, productssolution, solutiontraditional, traditionalapplication, applicationunknown, unknownmedicine, medicineplants, plantssanqi
METHODOLOGY FOR DETECTION AND STRUCTURAL CHARACTERIZATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR ADULTERANTS IN AN HERBAL COFFEE PRODUCT
2019|Waters|Posters
METHODOLOGY FOR DETECTION AND STRUCTURAL CHARACTERIZATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR ADULTERANTS IN AN HERBAL COFFEE PRODUCT Marian Twohig,1 Andy Aubin,1 Xiang Jin Song,1 Sarah Dowd,2 Gordon Fujimoto,2 Simon Hird3 1Waters Corporation, Milford, MA, USA; 2Waters Corporation, Beverly, MA, USA; 3Waters…
Key words
dart, dartsildenafil, sildenafilthiohomosildenafil, thiohomosildenafilfragments, fragmentsqda, qdatadalafil, tadalafiluplc, uplccaffeine, caffeineunknown, unknownhrms, hrmsprescription, prescriptioninitial, initialusing, usingfunctional, functionalscreen
METHODOLOGY FOR DETECTION AND STRUCTURAL CHARACTERIZATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR ADULTERANTS IN AN HERBAL COFFEE
2019|Waters|Posters
METHODOLOGY FOR DETECTION AND STRUCTURAL CHARACTERIZATION OF PHOSPHODIESTERASE-5 (PDE-5) INHIBITOR ADULTERANTS IN AN HERBAL COFFEE Marian Twohig,1 Andy Aubin,1 Xiang Jin Song,1 Sarah Dowd,2 Gordon Fujimoto,2 Simon Hird3 1 Waters Corporation, Milford, MA, USA; 2Waters Corporation, Beverly, MA, USA; 3Waters…
Key words
sildenafil, sildenafildart, dartcoffee, coffeeqda, qdanitrates, nitrateshrms, hrmsfoods, foodsstructural, structuralscreen, screenfragment, fragmentusing, usingunknown, unknowninitial, initialpda, pdaobserved